Abstract
From the previous chapters, the contributions which immunological knowledge has made to the understanding, diagnosis and treatment of ENT disorders can be assessed. It is possible, even likely, that, over the next few decades, immunological methods will provide greater input into this sphere.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harding SM. Human pharmacology of fluticasone. Allergologie. 1989;12:77,Abs. 04 04
Austin CE, Foreman JC, Scadding GK. [D-Arg0Hyp3Thi5D- Tic7Oic8]-bradykinin is an effective bradykinin antagonist in the human nasal airway. British Pharmacological Society Meeting Abstract, Rome, 1993
Walls AF. Liposomes for allergy immunotherapy? Clin Exp Allergy. 1992;22:3–6
Stanworth DR, Jones VM, Lewin IV, Nayyar S. Allergy treatment wit a peptide vaccine. Lancet. 1990;336:1279–81
O’Hehir RE, Lamb JR. Strategies for modulating IgE synthesis. Clin Exp Allergy. 1992;22: 7–10
Cookson W, Sharp PA, Faux JA, Hopkin J. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet. 1989;1:1292–5
Cole PJ. Host-microbe relationships in chronic respiratory disease. In: Reeves D, Geddes AM, eds. Recent advances in infection. Edinburgh: Churchill Livingstone; 1989:141–51
Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z et al. Identification of the cystic fibrosis gene: cloning and characteristics of complementary DNA. Science. 1989;245:1066–73
Steuer MK, Matthias R, Schulze C, Brusw T. Tntralesional therapy with natural interferon B in refractory squamous epithelial cancer of the ENT area. Laryngorhinootologie. 1992;71:618–25
Clayman GL, Young G, Taylor DL, Savage HE, Lavedan P, Schantz SP. Detection of regulatory factors of lymphokine activated killer cell activity in head and neck cancer patients treated with interleukin-2 and interferon alpha. Ann Otol-Rhinol-Laryngol. 1992;101:909–15
Gore ME, Riches P, Mallennan K et al. Phase i study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck. Br J Cancer. 1992;66:405–7
Mann EA, Spiro JD, Chen LL, Kreutzer DL. Cytokine expression by head and neck squamous cell carcinomas. Am J Surg. 1992;164:567–73
Kohler G, Milstein G. Continuous culture of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–7
Jones PT, Dear PH, Foote J, Neuberger MJ, WinterGReplacing the complementary-determining regions in a human antibody with those from a mouse. Nature. 19986;321:522–5
Skerra A, Pluckthün A. Assembly of a functional immunoglobulin Fc fragment in Escherichia coli. Science. 1988;240:1038–41
Orlandi R, Gusson DH, Jones PT, Winter G. Cloning immunoglobulin variable domains expression by the polymerase chain reaction. Proc Natl Acad Sci USA. 1989;86:3833–7
McCafferty J, Griffiths AD, Winter G, Chiswell DI. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 1990;348:552–4
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Scadding, G.K. (1994). Future Prospects for Immunological Involvement in ENT Disorders. In: Scadding, G.K. (eds) Immunology of ENT Disorders. Immunology and Medicine Series, vol 23. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1436-3_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-1436-3_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4629-9
Online ISBN: 978-94-011-1436-3
eBook Packages: Springer Book Archive